Watch EMN. Know when insiders buy.
One email the day a filing lands. Free.
EMN
EASTMAN CHEMICAL CO
68.11
−0.27 −0.39%
USD · close Sep 11
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
34
FLAG · shorts 34
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $7.8BP/E 17.7DIV YIELD 4.92%FCF YIELD 6.92%REV TTM $8.9B −4.5%NET INCOME $442M −46.9%NET DEBT $3.7B52W 56.37 – 81.36SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $2.5B | +9.9% | 22.3% | — | $183M | +30.7% | 1.59 | $224M | $100M | $124M | Jul 31 |
| Q1 2026 · Mar 31 | $2.2B | −4.9% | 19.8% | — | $107M | −41.2% | 0.93 | −$137M | $103M | −$240M | May 1 |
| Q4 2025 · Dec 31derived | $2B | −12.1% | 17.1% | — | $105M | −68.2% | 0.92 | $502M | $112M | $390M | Feb 13 |
| Q3 2025 · Sep 30 | $2.2B | −10.6% | 19.7% | — | $47M | −73.9% | 0.40 | $402M | $137M | $265M | Nov 4 |
| Q2 2025 · Jun 30 | $2.3B | −3.2% | 22.1% | — | $140M | −39.1% | 1.20 | $233M | $150M | $83M | Jul 31 |
| Q1 2025 · Mar 31 | $2.3B | −0.9% | 24.8% | — | $182M | +10.3% | 1.57 | −$167M | $147M | −$314M | May 1 |
| Q4 2024 · Dec 31derived | $2.2B | +1.7% | 24.7% | — | $330M | +6.5% | 2.81 | $540M | $179M | $361M | Feb 13 |
| Q3 2024 · Sep 30 | $2.5B | +8.7% | 24.6% | — | $180M | +1.1% | 1.53 | $396M | $120M | $276M | Nov 4 |
| Q2 2024 · Jun 30 | $2.4B | — | 25.3% | — | $230M | — | 1.94 | $367M | $115M | $252M | Aug 1 |
| Q1 2024 · Mar 31 | $2.3B | — | 23.0% | — | $165M | — | 1.39 | −$16M | $185M | −$201M | Apr 25 |
| Q4 2023 · Dec 31derived | $2.2B | — | 21.0% | — | $310M | — | 2.60 | $452M | $179M | $273M | Feb 13 |
| Q3 2023 · Sep 30 | $2.3B | — | 21.3% | — | $178M | — | 1.49 | $514M | $236M | $278M | Nov 1 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $8.8B | 21.1% | — | $474M | 5.4% | 4.10 | $970M | $546M | $424M | — | $381M |
| FY2024 · to Dec 31 | $9.4B | 24.4% | — | $905M | 9.6% | 7.67 | $1.3B | $599M | $688M | — | $379M |
| FY2023 · to Dec 31 | $9.2B | 22.4% | — | $894M | 9.7% | 7.49 | $1.4B | $828M | $546M | — | $376M |
| FY2022 · to Dec 31 | $10.6B | 20.2% | — | $793M | 7.5% | 6.35 | $975M | $611M | $364M | — | $381M |
| FY2021 · to Dec 31 | $10.5B | 23.9% | — | $857M | 8.2% | 6.25 | $1.6B | $555M | $1.1B | $900M | $375M |
| FY2020 · to Dec 31 | $8.5B | 23.3% | — | $478M | 5.6% | 3.50 | $1.5B | $383M | $1.1B | — | $358M |
Every number comes from EASTMAN CHEMICAL CO's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.